Successful Treatment of Paraneoplastic Cerebellar Degeneration with Rituximab

Overview

Journal J Neurooncol

Publisher Springer

Date 2007 Oct 10

PMID 17924058

Citations 15

Authors

Marcello Esposito

P Penza

G Orefice

A Pagano

E Parente

A Abbadessa

V Bonavita

Affiliations

Soon will be listed here.

Citing Articles

Ovarian mass Presenting as Paraneoplastic cerebellar degeneration with peripheral neuropathy and anti-Yo antibody.

Sahoo D, Dey A, Dash A, Dash A BMJ Case Rep. 2024; 17(1).

PMID: 38272525 PMC: 10826478. DOI: 10.1136/bcr-2023-257435.

Treatable Ataxias: How to Find the Needle in the Haystack?.

Stezin A, Pal P J Mov Disord. 2022; 15(3):206-226.

PMID: 36065614 PMC: 9536909. DOI: 10.14802/jmd.22069.

Update on Paraneoplastic Cerebellar Degeneration.

Loehrer P, Zieger L, Simon O Brain Sci. 2021; 11(11).

PMID: 34827413 PMC: 8615604. DOI: 10.3390/brainsci11111414.

Paraneoplastic Diseases of the Central Nervous System.

Galli J, Greenlee J F1000Res. 2020; 9.

PMID: 32194943 PMC: 7062203. DOI: 10.12688/f1000research.21309.1.

Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.

Mitoma H, Manto M, Hampe C Curr Neuropharmacol. 2018; 17(1):33-58.

PMID: 30221603 PMC: 6341499. DOI: 10.2174/1570159X16666180917105033.

References

Dalakas M . B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target. Pharmacol Ther. 2006; 112(1):57-70. DOI: 10.1016/j.pharmthera.2006.03.005. View

Sillevis Smitt P, Grefkens J, de Leeuw B, van den Bent M, van Putten W, Hooijkaas H . Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol. 2002; 249(6):745-53. DOI: 10.1007/s00415-002-0706-4. View

Shamsili S, de Beukelaar J, Gratama J, Hooijkaas H, van den Bent M, van t Veer M . An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol. 2006; 253(1):16-20. DOI: 10.1007/s00415-005-0882-0. View

Pescovitz M . Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant. 2006; 6(5 Pt 1):859-66. DOI: 10.1111/j.1600-6143.2006.01288.x. View

Trouillas P, Takayanagi T, Hallett M, CURRIER R, Subramony S, Wessel K . International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997; 145(2):205-11. DOI: 10.1016/s0022-510x(96)00231-6. View